Effectiveness of heterologous ChAdOx1 nCoV-19 and mRNA prime-boost vaccination against symptomatic Covid-19 infection in Sweden: A nationwide cohort study

BACKGROUND: The effectiveness of heterologous prime-boost Coronavirus disease 2019 (Covid-19) vaccination is currently unknown. METHODS: From individuals vaccinated with two doses against Covid-19 in Sweden until July 5, 2021 (N=3,445,061), we formed a study cohort including 94,569 individuals that...

Descripción completa

Detalles Bibliográficos
Autores principales: Nordström, Peter, Ballin, Marcel, Nordström, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8520818/
https://www.ncbi.nlm.nih.gov/pubmed/34693387
http://dx.doi.org/10.1016/j.lanepe.2021.100249

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8520818/
https://www.ncbi.nlm.nih.gov/pubmed/34693387
http://dx.doi.org/10.1016/j.lanepe.2021.100249

Ejemplares similares